Beryl Drugs has informed about submission of Annual Report for the Financial Year 2020-21 convening the 28th Annual General Meeting as required under Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.